Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00560794
What this trial is testing

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 21
Early research (Phase 1)Active Not RecruitingNCT05675449
What this trial is testing

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 59
Early research (Phase 1)Not Yet RecruitingNCT06015568
What this trial is testing

Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation

Who this might be right for
Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
Betta Pharmaceuticals Co., Ltd. 172
Early research (Phase 1)Looking for participantsNCT06410131
What this trial is testing

Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16

Who this might be right for
Solid Tumors
Sound Biopharmaceuticals Ltd. 68
Testing effectiveness (Phase 2)Ended earlyNCT04492033
What this trial is testing

CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Who this might be right for
P1b: Advanced Solid TumorsP2: Biliary Tract Cancer
Handok Inc. 41
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Early research (Phase 1)Study completedNCT03344250
What this trial is testing

Phase I EGFR BATs in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme
University of Virginia 16
Early research (Phase 1)Looking for participantsNCT07491900
What this trial is testing

HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)
Hinge Bio 30
Early research (Phase 1)Study completedNCT04991740
What this trial is testing

JNJ-78306358 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 39
Testing effectiveness (Phase 2)WithdrawnNCT03484962
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Fuda Cancer Hospital, Guangzhou
Early research (Phase 1)Study completedNCT00860860
What this trial is testing

Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Radboud University Medical Center 20
Early research (Phase 1)Looking for participantsNCT07622524
What this trial is testing

A Phase I Study of CS5007 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CStone Pharmaceuticals 310
Early research (Phase 1)Study completedNCT02651662
What this trial is testing

Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies

Who this might be right for
Relapsed/Refractory Aggressive B-Cell Lymphoma
Regeneron Pharmaceuticals 105
Testing effectiveness (Phase 2)Looking for participantsNCT03761108
What this trial is testing

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals 387
Testing effectiveness (Phase 2)Ended earlyNCT04469725
What this trial is testing

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 95
Early research (Phase 1)Not Yet RecruitingNCT06691360
What this trial is testing

AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 87
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06837948
What this trial is testing

Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

Who this might be right for
Locally Advanced Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 160
Not applicableStudy completedNCT06418750
What this trial is testing

Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study

Who this might be right for
Myeloma Multiple
Nantes University Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06477523
What this trial is testing

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Sichuan University 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06310473
What this trial is testing

Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial

Who this might be right for
Gastric CancerEsophagogastric Junction Cancer
Nanfang Hospital, Southern Medical University 30
Next Page